Jupiter Research Capital (Asia) Ltd’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Jupiter Research Capital (Asia) Ltd's AXSM Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 24,763 shares — an estimated $6.06M sold.
Jupiter Research Capital (Asia) Ltd first reported a position in AXSM in Q2 2026 and held it in 1 quarter. The position peaked at $6.06M in Q2 2026. 446 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 24,763 Axsome Therapeutics shares in Q3 2026, an estimated $6.06M.
- Jupiter Research Capital (Asia) Ltd first reported a position in Axsome Therapeutics in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's Axsome Therapeutics position peaked at $6.06M in Q2 2026.
- 446 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.